secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0001477932-23-006695
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bionexus Gene Lab COO Liong Tai Tan resigns; Lee Su-Leng Tan appointed COO
--------------------------------------------------------------------------

- Liong Tai Tan resigned as COO and director effective August 31, 2023; no disagreement with company.
- Board approved Lee Su-Leng Tan as COO effective September 1, 2023; he is not a director.
- Lee Su-Leng Tan, aged 40, has over 20 years of experience in life sciences, hospitality, and property.
- New COO entered employment agreement dated August 15, 2023, with annual compensation of $24,000.
- Tan previously served as Chief Commercial Officer at Dryox Health and Managing Director at Biotechnology Group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793223006695/0001477932-23-006695-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793223006695/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-006695

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer